Identification |
Name: | Fosamprenavir calcium |
Synonyms: | Carbamicacid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-,C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1) (9CI);Carbamic acid,N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-,(3S)-tetrahydro-3-furanyl ester, calcium salt (1:1);Lexiva;(3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R)-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1); |
CAS: | 226700-81-8 |
Molecular Formula: | C25H34CaN3O9PS |
Molecular Weight: | 623.67 |
InChI: | InChI=1/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/t21-,23-,24+;/m0./s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 282-284 oC |
Appearance: | white microcrystalline needles |
Specification: |
?Fosamprenavir calcium (CAS NO.226700-81-8), its Synonyms are ((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-(phosphonooxy)propyl)carboxamide calcium salt ; (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R)-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1) ; Amprenavir phosphate calcium ; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt (1:1) ; Lexiva ; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-ethylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt . It is white microcrystalline needles.?
|
Usage: | Fosamprenavir calcium (CAS NO.226700-81-8) is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. |
Safety Data |
|
|